Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1331779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Hyeong Won Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Foot-and-Mouth Disease Vaccine Research, Animal and Plant Quarantine Agency, Gimcheon-si, Gyeongsangbuk-do, Republic of Korea. Hauptthemen laut MEDLINE: Foot-and-Mouth Disease, Inosine Pranobex, Foot-and-Mouth Disease Virus, Viral Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Animal and Plant Quarantine Agency.
Abstract (Originalsprache)
Background
Commercial foot-and-mouth disease (FMD) vaccines have limitations, such as local side effects, periodic vaccinations, and weak host defenses. To overcome these limitations, we developed a novel FMD vaccine by combining an inactivated FMD viral antigen with the small molecule isoprinosine, which served as an adjuvant (immunomodulator).
Method
We evaluated the innate and adaptive immune responses elicited by the novel FMD vaccine involved both in vitro and in vivo using mice and pigs.
Results
We demonstrated isoprinosine-mediated early, mid-term, and long-term immunity through in vitro and in vivo studies and complete host defense against FMD virus (FMDV) infection through challenge experiments in mice and pigs. We also elucidated that isoprinosine induces innate and adaptive (cellular and humoral) immunity via promoting the expression of immunoregulatory gene such as pattern recognition receptors [PRRs; retinoic acid-inducible gene (RIG)-I and toll like receptor (TLR)9], transcription factors [T-box transcription factor (TBX)21, eomesodermin (EOMES), and nuclear factor kappa B (NF-kB)], cytokines [interleukin (IL)-12p40, IL-23p19, IL-23R, and IL-17A)], and immune cell core receptors [cluster of differentiation (CD)80, CD86, CD28, CD19, CD21, and CD81] in pigs.
Conclusion
These findings present an attractive strategy for constructing novel FMD vaccines and other difficult-to-control livestock virus vaccine formulations based on isoprinosine induced immunomodulatory functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Foot-and-Mouth Disease Vaccine Research, Animal and Plant Quarantine Agency, Gimcheon-si, Gyeongsangbuk-do, Republic of Korea.
Förderung
- Animal and Plant Quarantine Agency
Zitieren
APA
Kim, H. W., Ko, M. K., Shin, S., Park, S. H., Park, J. H., Kim, S. M., & Lee, M. J. (2024). Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1331779
Vancouver
Kim HW, Ko MK, Shin S, Park SH, Park JH, Kim SM, et al. Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1331779
BibTeX
@article{Kim2024,
author = {Kim, Hyeong Won and Ko, Mi-Kyeong and Shin, Seokwon and Park, So Hui and Park, Jong-Hyeon and Kim, Su-Mi and Lee, Min Ja},
title = {Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1331779}
}
EUVIMED